Molecular Insights into the Mechanism of Necroptosis: The Necrosome As a Potential Therapeutic Target.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
21 11 2019
Historique:
received: 30 10 2019
revised: 13 11 2019
accepted: 19 11 2019
entrez: 27 11 2019
pubmed: 27 11 2019
medline: 18 8 2020
Statut: epublish

Résumé

Necroptosis, or regulated necrosis, is an important type of programmed cell death in addition to apoptosis. Necroptosis induction leads to cell membrane disruption, inflammation and vascularization. It plays important roles in various pathological processes, including neurodegeneration, inflammatory diseases, multiple cancers, and kidney injury. The molecular regulation of necroptotic pathway has been intensively studied in recent years. Necroptosis can be triggered by multiple stimuli and this pathway is regulated through activation of receptor-interacting protein kinase 1 (RIPK1), RIPK3 and pseudokinase mixed lineage kinase domain-like (MLKL). A better understanding of the mechanism of regulation of necroptosis will further aid to the development of novel drugs for necroptosis-associated human diseases. In this review, we focus on new insights in the regulatory machinery of necroptosis. We further discuss the role of necroptosis in different pathologies, its potential as a therapeutic target and the current status of clinical development of drugs interfering in the necroptotic pathway.

Identifiants

pubmed: 31766571
pii: cells8121486
doi: 10.3390/cells8121486
pmc: PMC6952807
pii:
doi:

Substances chimiques

MLKL protein, human EC 2.7.-
Protein Kinases EC 2.7.-
RIPK1 protein, human EC 2.7.11.1
RIPK3 protein, human EC 2.7.11.1
Receptor-Interacting Protein Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare that no conflicts of interest.

Références

Oncoscience. 2014 Oct 22;1(10):649-64
pubmed: 25593994
Nat Commun. 2016 Jan 28;7:10274
pubmed: 26817517
Cell Host Microbe. 2010 Apr 22;7(4):302-13
pubmed: 20413098
Cell Death Dis. 2016 Feb 11;7:e2089
pubmed: 26866270
J Am Chem Soc. 2018 Feb 14;140(6):2301-2308
pubmed: 29377688
Mol Cell. 2018 Jun 7;70(5):936-948.e7
pubmed: 29883610
Biochem J. 2013 Dec 15;456(3):409-15
pubmed: 24059293
J Immunol. 2014 Aug 15;193(4):1539-1543
pubmed: 25015821
Basic Res Cardiol. 2012 Jul;107(4):270
pubmed: 22553001
Cell Death Differ. 2017 Jul;24(7):1184-1195
pubmed: 28498367
Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5675-5680
pubmed: 30837313
Oncotarget. 2018 Feb 5;9(16):12941-12958
pubmed: 29560122
Int J Mol Sci. 2018 Oct 09;19(10):null
pubmed: 30304824
Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):11944-11949
pubmed: 29078411
Nat Neurosci. 2017 Sep;20(9):1236-1246
pubmed: 28758999
J Biol Chem. 2017 Oct 20;292(42):17514-17524
pubmed: 28878015
J Biol Chem. 2012 Apr 27;287(18):14863-72
pubmed: 22362767
Trends Cancer. 2017 Apr;3(4):294-301
pubmed: 28451648
Semin Cell Dev Biol. 2015 Mar;39:56-62
pubmed: 25683283
Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1475-E1484
pubmed: 29382757
Nat Immunol. 2015 Jun;16(6):618-27
pubmed: 25939025
Immunity. 2013 Sep 19;39(3):443-53
pubmed: 24012422
Mol Metab. 2019 May;23:14-23
pubmed: 30837196
Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):E5944-E5953
pubmed: 29891719
Cell Rep. 2018 Feb 20;22(8):2066-2079
pubmed: 29466734
Sci Adv. 2016 Jul 22;2(7):e1600224
pubmed: 27532042
Lab Invest. 2019 Sep 10;:null
pubmed: 31506635
J Biol Chem. 2013 Oct 25;288(43):31268-79
pubmed: 24019532
Nat Commun. 2016 Jun 21;7:11869
pubmed: 27323669
Cell Rep. 2012 May 31;1(5):401-7
pubmed: 22675671
Annu Rev Immunol. 2015;33:79-106
pubmed: 25493335
Front Immunol. 2019 Apr 04;10:615
pubmed: 31019504
Nature. 2015 Jan 15;517(7534):311-20
pubmed: 25592536
Mol Cell. 2016 Oct 20;64(2):236-250
pubmed: 27746017
Sci Rep. 2017 Aug 31;7(1):10133
pubmed: 28860618
Redox Biol. 2018 Jun;16:157-168
pubmed: 29502045
J Biol Chem. 2006 May 12;281(19):13636-43
pubmed: 16543241
Cell Death Dis. 2015 May 21;6:e1767
pubmed: 25996294
Nat Commun. 2019 Apr 15;10(1):1729
pubmed: 30988283
Exp Mol Med. 2018 Sep 20;50(9):125
pubmed: 30237400
Oncotarget. 2015 Apr 20;6(11):8635-47
pubmed: 25888634
Mol Cell. 2006 Apr 21;22(2):245-57
pubmed: 16603398
PLoS One. 2016 Jun 09;11(6):e0156729
pubmed: 27281190
Cell Death Dis. 2015 Sep 10;6:e1884
pubmed: 26355347
Cell. 2008 May 16;133(4):693-703
pubmed: 18485876
Cell Rep. 2013 Jan 31;3(1):200-10
pubmed: 23333278
J Med Chem. 2017 Feb 23;60(4):1247-1261
pubmed: 28151659
J Immunol. 2016 Oct 15;197(8):3120-3129
pubmed: 27605011
Nature. 2016 Dec 1;540(7631):129-133
pubmed: 27819682
Cell Mol Immunol. 2010 Jul;7(4):243-9
pubmed: 20383176
J Biol Chem. 2016 Mar 11;291(11):5948-59
pubmed: 26786097
Nat Commun. 2018 Jun 21;9(1):2422
pubmed: 29930286
Cell Death Differ. 2016 Feb;23(2):253-60
pubmed: 26184911
Cell. 2003 Jul 25;114(2):181-90
pubmed: 12887920
Cell Rep. 2014 May 22;7(4):971-81
pubmed: 24813885
J Med Chem. 2017 Feb 9;60(3):972-986
pubmed: 27992216
Mol Cell Biol. 2017 Feb 15;37(5):
pubmed: 27920255
Mol Cell. 2011 Aug 5;43(3):449-63
pubmed: 21737330
Cell Host Microbe. 2016 Jul 13;20(1):13-24
pubmed: 27321907
Cell Death Differ. 2016 Oct;23(10):1628-37
pubmed: 27258786
Nature. 2016 Dec 1;540(7631):124-128
pubmed: 27819681
Nat Commun. 2017 Aug 25;8(1):359
pubmed: 28842570
Annu Rev Pathol. 2017 Jan 24;12:103-130
pubmed: 27959630
Cell Death Differ. 2019 Oct 7;:null
pubmed: 31591470
Mol Cell. 2015 Oct 1;60(1):63-76
pubmed: 26344099
Cell Death Dis. 2016 Jan 14;7:e2051
pubmed: 26775703
FEBS J. 2014 Nov;281(21):4921-34
pubmed: 25195660
Trends Pharmacol Sci. 2017 Mar;38(3):202-225
pubmed: 28126382
Commun Biol. 2018 Jan 22;1:6
pubmed: 30271893
Cancer Cell. 2016 Jul 11;30(1):75-91
pubmed: 27411587
Nature. 1997 Jul 10;388(6638):190-5
pubmed: 9217161
Proc Natl Acad Sci U S A. 2017 Sep 5;114(36):E7450-E7459
pubmed: 28827318
J Anesth. 2014 Apr;28(2):235-41
pubmed: 24113863
Cell. 2012 Jan 20;148(1-2):213-27
pubmed: 22265413
Oncotarget. 2016 Jul 19;7(29):46384-46400
pubmed: 27344176
Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):E2001-E2009
pubmed: 29440439
J Transl Med. 2019 Mar 15;17(1):84
pubmed: 30876479
Immunity. 1996 Apr;4(4):387-96
pubmed: 8612133
Nat Chem Biol. 2005 Jul;1(2):112-9
pubmed: 16408008
Mol Cell. 2016 Feb 18;61(4):589-601
pubmed: 26853145
J Biol Chem. 2009 Jul 31;284(31):20531-9
pubmed: 19506082
Cell Rep. 2015 Mar 24;10(11):1836-49
pubmed: 25801023
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15072-7
pubmed: 25288762
Mol Cell. 2016 Mar 17;61(6):834-49
pubmed: 26990987
Clin Sci (Lond). 2019 Jul 25;133(14):1609-1627
pubmed: 31315969
Biochem J. 2015 Oct 15;471(2):255-65
pubmed: 26283547
Cell Death Dis. 2015 Feb 12;6:e1636
pubmed: 25675296
Nat Cell Biol. 2016 Mar;18(3):291-302
pubmed: 26900751
Cell Death Differ. 2016 Jan;23(1):76-88
pubmed: 26024392
Mol Ther Nucleic Acids. 2019 Sep 6;17:701-713
pubmed: 31422287
Cell Death Differ. 2014 Oct;21(10):1600-12
pubmed: 24902899
PLoS One. 2016 Nov 10;11(11):e0165983
pubmed: 27832137
Science. 2014 Mar 21;343(6177):1357-60
pubmed: 24557836
Cancer Biomark. 2017 Jul 19;20(1):23-29
pubmed: 28759952
Cell Res. 2015 Jun;25(6):707-25
pubmed: 25952668
Proc Natl Acad Sci U S A. 2017 Oct 10;114(41):E8788-E8797
pubmed: 28904096
Nat Cell Biol. 2014 Jan;16(1):55-65
pubmed: 24316671
Science. 2016 Aug 5;353(6299):603-8
pubmed: 27493188
Immunity. 2017 Jul 18;47(1):51-65.e7
pubmed: 28666573
Cell Death Dis. 2014 Jun 05;5:e1278
pubmed: 24901049
Cell Res. 2014 Jan;24(1):105-21
pubmed: 24366341
Apoptosis. 2017 May;22(5):626-638
pubmed: 28289909
Chem Commun (Camb). 2017 Mar 28;53(26):3637-3640
pubmed: 28267172
Nat Immunol. 2015 Jul;16(7):689-97
pubmed: 26086143

Auteurs

Jing Chen (J)

Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3508 TB Utrecht, The Netherlands.

Renate Kos (R)

Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3508 TB Utrecht, The Netherlands.

Johan Garssen (J)

Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3508 TB Utrecht, The Netherlands.
Danone Nutricia Research, Uppsalaan 12, 3584 CT, Utrecht, The Netherlands.

Frank Redegeld (F)

Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3508 TB Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH